Specifically, EphA4 serves as a substrate for γ-secretase, a protease that malfunctions in many early-onset AD cases, while the overexpression of EphA4 increases the number of dendritic spines by activating the Rac signaling pathway [251]. Here, AKT1 is linked to Alzheimer disease.